Flurbiprofen

BreastfeedingGeriatric
  • TRADE NAMES: Ansaid (Pfizer); Apo-Flurbiprofen; Cebutid; Flurofen; Flurozin; Froben; Lapole; Nu-Flurprofen
  • INDICATIONS: Rheumatoid arthritis, osteoarthritis
  • CLASS: Non-steroidal anti-inflammatory (NSAID)
  • HALF-LIFE: 3–4 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

ACE inhibitors, Aspirin, Furosemide, Lithium, Methotrexate

PREGNANCY CATEGORY: C

NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.

Elderly patients are at greater risk for serious gastrointestinal events.

CARDIOVASCULAR AND GASTROINTESTINAL RISKS

See full prescribing information for complete boxed warning

Our database has 42 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
NAILS
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
GASTROINTESTINAL/HEPATIC
OCULAR
RENAL
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top